Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities

Página do item simplificado
dc.contributor.authorRocha, Leticia B.
dc.contributor.authorLuz, Daniela E.
dc.contributor.authorMoraes, Claudia T. P.
dc.contributor.authorCaravelli, Andressa
dc.contributor.authorFernandes, Irene
dc.contributor.authorGuth, Beatriz Ernestina Cabilio [UNIFESP]
dc.contributor.authorHorton, Denise S. P. Q.
dc.contributor.authorPiazza, Roxane M. F.
dc.contributor.institutionButantan Inst
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.date.accessioned2016-01-24T14:27:36Z
dc.date.available2016-01-24T14:27:36Z
dc.date.issued2012-09-01
dc.description.abstractMonoclonal antibodies (MAbs) have been employed either for diagnosis or treatment of infections caused by different pathogens. Specifically for Shiga toxin-producing Escherichia coli (STEC), numerous immunoassays have been developed for STEC diagnosis, showing variability in sensitivity and specificity when evaluated by reference laboratories, and no therapy or vaccines are currently approved. Thus, the aim of this work was the characterization of the interaction between MAbs against Stx1 and Stx2 toxins and their neutralizing abilities to enable their use as tools for diagnosis and therapy. the selected clones designated 3E2 (anti-Stx1) and 2E11 (anti-Stx2) were classified as IgG1. 3E2 recognized the B subunit of Stx1 with an affinity constant of 2.5 x 10(-10) M, detected as little as 6.2 ng of Stx1 and was stable up to 50 degrees C. in contrast, 2E11 recognized the A subunit of Stx2, was stable up to 70 degrees C, had a high dissociation constant of 6.1 x 10(-10) M, and detected as little as 12.5 ng of Stx2. Neutralization tests showed that 160 ng of 3E2 MAb inhibited 80% of Stx1 activity and 500 mu g 2E11 MAb were required for 60% inhibition of Stx2 activity. These MAb amounts reversed 25 to 80% of the cytotoxicity triggered by different STEC isolates. in conclusion, these MAbs show suitable characteristics for their use in STEC diagnosis and encourage future studies to investigate their protective efficacy.en
dc.description.affiliationButantan Inst, Bacteriol Lab, São Paulo, Brazil
dc.description.affiliationButantan Inst, Immunopathol Lab, São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Dept Microbiol, Escola Paulista Med, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Microbiol, Escola Paulista Med, São Paulo, Brazil
dc.description.sourceWeb of Science
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.format.extent729-747
dc.identifierhttp://dx.doi.org/10.3390/toxins4090729
dc.identifier.citationToxins. Basel: Mdpi Ag, v. 4, n. 9, p. 729-747, 2012.
dc.identifier.doi10.3390/toxins4090729
dc.identifier.fileWOS000315405900007.pdf
dc.identifier.issn2072-6651
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/35200
dc.identifier.wosWOS:000315405900007
dc.language.isoeng
dc.publisherMdpi Ag
dc.relation.ispartofToxins
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectStx1en
dc.subjectStx2en
dc.subjectmonoclonal antibodiesen
dc.subjectbindingen
dc.subjectstabilityen
dc.subjectdetectionen
dc.subjectneutralizing abilityen
dc.subjectspecificityen
dc.titleInteraction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilitiesen
dc.typeinfo:eu-repo/semantics/article
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
WOS000315405900007.pdf
Tamanho:
1.35 MB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
Coleções
EPM - Artigos